TOP NEWS: GSK, Vir To Probe Second Virus Antibody In NHS-Backed Trial Read More
UK Dividends Calendar - Next 7 Days Read More
UK DIRECTOR DEALINGS SUMMARY: Rio Tinto Copper & Diamonds Chief Sells Read More
Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation Read More
TOP NEWS: Glaxo Receives EU Marketing Authorisation For HIV Treatment Read More
LONDON MARKET PRE-OPEN: Frasers Pulls Guidance Amid Fresh Restrictions Read More
LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound Read More
GlaxoSmithKline And Vir Biotechnology Kick Off ACTIV-3 Covid Trial Read More
Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus Read More
UK BROKER RATINGS SUMMARY: BofA Rates Rotork Buy, Weir Underperform Read More
SIG Appoints 30-Year Human Resource Veteran Kath Durrant To Board Read More
Glaxo's ViiV Gets Positive EU Committee Approval For HIV Drug Rukobia Read More
TOP NEWS: Glaxo And Sanofi's Covid-19 Vaccine Delayed To End Of 2021 Read More
LONDON MARKET EARLY CALL: Flat Call As No-Deal Brexit Moves Closer Read More
Glaxo's Nucala Accepted By US FDA As Treatment For Rhinosinusitis Read More
UK BROKER RATINGS SUMMARY: Jefferies Raises Whitbread And Cuts IHG Read More
UK BROKER RATINGS SUMMARY: Bernstein Boosts Shell To Outperform Read More
IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials Read More
Glaxo, Pfizer's HIV Tablet Treatment Gets Positive Opinion In EU Read More
